Early elevation of transforming growth factor-β, decorin, and biglycan mRNA levels during cartilage matrix restoration after mild proteoglycan depletion

Journal of Rheumatology

Volumn 24, Issue 3, 1997, Pages 543-549

  Van Der Kraan, Peter M ^a   Glansbeek, Harrie L ^a   Vitters, Elly L ^a   Van Den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

aggrecan; biglycan; cartilage; decorin; repair; transforming growth factor

Indexed keywords

AGGRECAN; BIGLYCAN; DECORIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE MATRIX; CONTROLLED STUDY; MOUSE; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS;

AGGRECANS; ANIMALS; CARTILAGE, ARTICULAR; EXTRACELLULAR MATRIX PROTEINS; KNEE JOINT; LECTINS, C-TYPE; MALE; MICE; MICE, INBRED C57BL; PAPAIN; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; REGENERATION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 0030954977     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Fassbender HG: Histomorphological basis of articular cartilage destruction in rheumatoid arthritis. Coll Relat Res 1983;3:141-51.
2. Brandt KD: Osteoarthritis. Clin Geriatr Med 1988;4:219-93.
3. Mankin HJ: Current concept review. The response of articular cartilage to injury. J Bone Joint Surg 1982;64A:460-6.
4. Hardingham TE, Bayliss MB: Proteoglycans of articular cartilage: Changes in aging and in joint disease. Semin Arthritis Rheum 1990;20:12-33.
5. Hardingham TE, Fosang AJ: Proteoglycans: Many forms and many functions. FASEB J 1992;6:861-70.
6. Eyre D, Wu JJ, Apone S: A growing family of collagens in articular cartilage: Identification of 5 genetically distinct types. J Rheumatol 1987;14:25-1.
7. Border WA, Ruoslahti E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 1992;90:1-7.
8. Levine JH, Moses HL, Gold LI, Nanney LB: Spatial and temporal patterns of immunoreactive transforming growth factor β1, β2 and β3 during excisional wound repair. Am J Pathol 1993;143:368-80.
9. Martin P, Dickson MC, Millan FA, Akhurst RJ: Rapid induction and clearance of TGF β1 is an early response to wounding in the mouse embryo. Develop Gen 1993;14:225-38.
10. Beck LS, DeGuzman L, Lee WP, et al: TGF-β induces bone closure of skull defects. J Bone Min Res 1991;6:1257-65.
11. Glaser BM, Michels RG, Kuppermann BD, Sjaarda RN, Pena RA: Transforming growth factor-β2 for the treatment of full thickness macular holes. Ophthalmology 1992;99:1162-73.
12. Lefer AM: Mechanisms of the protective effects of transforming growth factor β in reperfusion injury. Biochem Pharmacol 1991;42:1323-7.
13. Cromack DT, Porras-Reyes B, Purdy JA, Pierce GF, Mustoe TA: Acceleration of tissue repair by transforming growth factor β1: Identification of in vivo mechanism of action with radiotherapy-induced specific healing deficits. Surgery 1993;113:36-42.
14. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN: Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: Implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol 1992;31:653-61.
15. Van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB: Protection from interleukin-1 induced destruction of articular cartilage by transforming growth factor β: Studies in anatomically intact cartilage in vitro and vivo. Ann Rheum Dis 1993;52:185-91.
16. Van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB: In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-β1. Age related differences. Ann Rheum Dis 1994;53:593-600.
17. Poole AR, Webber C, Pidoux I, Choi H, Rosenberg LC: Localization of a dermatan sulfate proteoglycan (DS-PGII) in cartilage and the presence of an immunologically related species in other tissues. J Histochem Cytochem 1986;34:619-25.
18. Poole AR, Fisher LW, Young MF, Termine JD, Robey PG: Expression and localization of the 2 small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 1990:38:1549-63.
19. Romaris M, Heredia A, Molist A, Bassols A: Differential effect of transforming growth factor βon proteoglycan synthesis in human embryonic lung fibroblasts. Biochim Biophys Acta 1991;1093:229-33.
20. Kähäri VM, Larjava H, Uitto J: Differential regulation of extracellular matrix proteoglycan (PG) gene expression. J Biol Chem 1991;266:10608-15.
21. Roughley PJ, Melching LI, Recklies AD: Changes in the expression of decorin and biglycan in human articular cartilage with age and regulation by TGF-β. Matrix Biol 1994;14:51-9.
22. Border WA, Okuda S, Languino LR, Ruoslahti E: Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 1990;37:689-95.
23. Ruoslahti E, Yamaguchi Y, Hildebrand A, Border WA: Extracellular matrix/growth factor interactions. Cold Spring Harbor Symp Quant Biol 1992;72:309-15.
24. Hildebrand A, Romaris M, Rasmussen LM, et al: Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor β. Biochem J 1994;302:527-34.
25. Border WA, Noble NA, Yamamoto T, Tomooka S, Kagami S: Antagonist of transforming growth factor-β. A novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int 1992;41:566-70.
26. Hausser H, Gröning A, Haslik A, Schönherr E, Kresse H: Selective inactivity of TGF-β/decorin complexes. FEBS Lett 1994;353:243-5.
27. Takeuchi Y, Kodama Y, Matsumoto T: Bone matrix decorin binds transforming growth factor-β and enhances its bioactivity. J Biol Chem 1994;269:32634-8.
28. Van der Kraan PM, Vitters EL, van de Putte LBA, van den Berg WB: Development of osteoarthritic lesions in mice by "metabolic" and "mechanical" alterations in the knee joints. Am J Pathol 1989;135:1001-14.
29. Van den Berg WB, Kruijsen MWM, van de Putte LBA: The mouse patella assay. An easy method of quantitating articular cartilage chondrocyte function in vivo and vitro. Rheumatol Int 1982;1:165-9.
30. Grover J, Roughly PJ: Versican gene expression in human articular cartilage and comparison of mRNA splicing with aggrecan. Biochem J 1993;291:361-7.
31. Asundi VK, Dreher KL: Molecular characterization of vascular smooth muscle decorin: Deduced core protein structure and regulation of gene expression. Eur J Cell Biol 1992;59:314-21.
32. Mulheron GW, Mulheron JG, Danielpour D, Schomberg DW: Porcine granulosa cells do not express transforming growth factor-β2 (TGF β2) messenger ribonucleic acid: Molecular basis for their inability to produce TGF-β activity comparable to that of rat granulosa cells. Endocrinology 1992;131:2609-14.
33. Bützow R, Fukushima D, Twardik DR, Ruoslahti E: A 60-Kd protein mediates the binding of transforming growth factor-β to the cell surface and extracellular matrix proteoglycans. J Cell Biol 1993;122:721-7.
34. Miyazono K, Ichijo H, Heldin CH: Transforming growth factor-β: Latent forms, binding proteins and receptors. Growth Fact 1993;8:11-22.
35. Taipale J, Miyazono K, Heldin CH, Keski-Oja J: Latent transforming growth factor-β1 associates to fibroblasts extracellular matrix via latent TGF-β binding protein. J Cell Biology 1994;125:171-81.
36. Morén A, Olofsson A, Stenman G, et al: Identification and characterization of LTBP-2, a novel latent transforming growth factor-β-binding protein. J Biol Chem 1994;269:32469-78.
37. Morales TI, Joyce MA, Sobel ME, Danielpour D, Roberts AB: Transforming growth factor-β in calf articular cartilage organ cultures: Synthesis and distribution. Arch Biochem Biophys 1991;288:397-405.
38. Collier S, Ghosh P: Effects of transforming growth factor beta on proteoglycan synthesis by cell and explant cultures derived from the knee joint meniscus. Osteoarthritis Cart 1995;3:127-38.
39. Vogel KG, Paulsson M, Heinegard D: Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 1984;223:587-97.
40. Bidanset DJ, Guidry C, Rosenberg LC, Choi HU, Timpl R, Höök M: Binding of proteoglycan decorin to collagen type VI. J Biol Chem 1992;267:643-8.
41. Winnemöller M, Schmidt G, Kresse H: Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol 1991;54:10-7.
42. Winnemöller M, Schön P, Vischer P, Kresse H: Interactions between thrombospondin and the small proteoglycan decorin: Interference with cell attachment. Eur J Cell Biol 1992;59:47-55.
43. Cs-Szabo G, Roughly PJ, Melching LI, Kuettner KE, Glant TT: Expression of proteoglycans in human osteoarthritic cartilage measured by quantitative-PCR (abstr). Transactions of the 42nd Annual Meeting. ORS 1996;21:221.